1 recruiting. 1 Phase 1, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 1 | Recruiting 1 |
| Phase 2 | 1 | Recruiting 1 |
Follow VIR-7832: new trials by email Literature Review of VIR-7832 trials Research Report on VIR-7832
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| AGILE (Early Phase Platform Trial for COVID-19) CST-2: EIDD-2801, CST-2: Placebo, Nitazoxanide - Covid19 | Phase 1 / Phase 2 | Recruiting | University of Liverpool | 600 | 2020-07-03 | 2026-06-01 |
COVID-19 (1)
South Africa (1) · United Kingdom (1)
Saye Khoo (1)
PMID 34450619, PMID 34473343, PMID 34699618, PMID 35271729, PMID 36272432, PMID 36435798, PMID 41848748